泰利医疗 TDOC
$8.77 −$0.64 (-6.80%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $8.75 -0.23%
开盘$9.20
昨收$9.41
当日区间$8.75 – $9.45
成交量5.73M
市值$1.60B
市盈率（TTM）–
股息率–
财报
财报日平均波动±11.1%近16次财报
收涨次数7 / 1644% 的概率
最佳反应+27.0%
最差反应-28.3%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 28 Oct 2026 | After Market | ±9.2% | +26.89% | 超出定价预期 |
| 2026/Q2 | 29 Jul 2026 | After Market | ±9.5% | -28.32% | 超出定价预期 |
| 2026/Q1 | 29 Apr 2026 | After Market | ±8.0% | +1.85% | 符合区间 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±9.2% | +15.05% | 超出定价预期 |
| 2025/Q3 | 29 Oct 2025 | After Market | ±7.9% | +6.20% | 符合区间 |
| 2025/Q2 | 29 Jul 2025 | After Market | ±11.8% | -1.73% | 符合区间 |
| 2025/Q1 | 30 Apr 2025 | After Market | ±13.7% | -2.78% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±14.1% | -13.56% | 符合区间 |
| 2024/Q3 | 30 Oct 2024 | After Market | ±13.2% | +1.58% | 符合区间 |
| 2024/Q2 | 31 Jul 2024 | After Market | ±15.8% | -8.91% | 符合区间 |
| 2024/Q1 | 25 Apr 2024 | After Market | ±14.1% | -2.40% | 符合区间 |
| 2023/Q4 | 20 Feb 2024 | After Market | ±17.0% | -23.67% | 超出定价预期 |
| 2023/Q3 | 24 Oct 2023 | After Market | ±14.0% | -3.92% | 符合区间 |
| 2023/Q2 | 25 Jul 2023 | After Market | ±13.3% | +26.95% | 超出定价预期 |
| 2023/Q1 | 26 Apr 2023 | After Market | ±13.0% | +6.36% | 符合区间 |
| 2022/Q4 | 22 Feb 2023 | After Market | ±15.8% | -6.80% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q3, ended Sep 2026
营收$605.10M-3.4% YoY
营业利润-$22.13M+37.6% YoY
净利润-$26.93M+45.6% YoY
摊薄每股收益-$0.15+46.4% YoY
自由现金流$75.94M+11.8% YoY
经营现金流$106.46M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率68.6%
营业利润率-5.4%
净利率-6.3%
净资产收益率-11.5%
资产收益率-5.5%
投入资本回报率-6.8%
流动比率0.87
负债/资产比率53.3%
现金及投资$849.91M
总负债$1.03B
净现金（净负债）-$175.81M
自由现金流/营收5.1%
暂无评论——快来第一个聊聊 TDOC。
登录后参与讨论。